NCT04209777View on ClinicalTrials.gov

Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 8, 2018

Primary Completion Date

April 16, 2019

Study Completion Date

May 6, 2019

Conditions
Periodontal DiseasesSmoking
Interventions
DRUG

Probiotic Blend Chewable Tablet

Lactobacillus-reuteri probiotics were used as an experimental drug.

DRUG

Antibiotics

Amoxicillin capsules 500mg and metronidazole tablets 400mg antibiotics were used as an active comparator.

Trial Locations (1)

Unknown

Mehwish Ghazal, Karachi

All Listed Sponsors
lead

Dow University of Health Sciences

OTHER

NCT04209777 - Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy | Biotech Hunter | Biotech Hunter